Skip to main content
SpringerLink
Log in

Laser Treatment for Vulvovaginal Atrophy

  • Chapter
  • First Online:
Postmenopausal Diseases and Disorders

Abstract

Laser therapy has a therapeutic role for different medical conditions and most recently has gained interest as a non-hormonal treatment for vulvovaginal atrophy or genitourinary syndrome of menopause (GSM). Both microablative fractional CO2 laser and the second-generation non-ablative vaginal Er:YAG laser (VEL) can alleviate the symptoms of dryness and dyspareunia. VEL was also reported to improve SUI as well as vaginal prolapse. The currently available data on the effects of laser on GSM in peer-reviewed publications unequivocally demonstrate the clinical effectiveness of laser therapies on GSM-related symptoms, associated with a high tolerability and a negligible rate of short-term complications. Some controversial issues remain to be solved as the preferred energy-based device, namely, CO2 versus VEL, i.e., ablative versus non-ablative technology. Although comparative, randomized trials have not been reported to date, existing evidences suggest that non-ablative VEL can be offered as a safe and efficacious therapy for GSM, due to the high efficacy, the duration, and the intrinsic safety of repeated applications. Studies will still be necessary to evaluate the additive effect of local or systemic treatments in conjunction with laser treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Portman DJ, Gass MLS, on behalf of the Vulvovaginal Atrophy Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Climacteric. 2014;17(5):557–63.

    Article  CAS  Google Scholar 

  2. Management of symptomatic vulvovaginal atrophy: 2013 position statement of the North American Menopause Society. Menopause. 2013;20:888–902.

    Google Scholar 

  3. Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, Santen RJ. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975–4011.

    Article  CAS  Google Scholar 

  4. Palacios S, Castelo-Branco C, Currie H, Mijatovic V, et al. Update on management of genitourinary syndrome of menopause: a practical guide. Maturitas. 2015;82:307–12.

    Google Scholar 

  5. Gambacciani M, Biglia N, Cagnacci A, Caruso S, Cicinelli E, DE Leo V, DI Carlo C, Farris M, Gambera A, Guaschino S, Lanzone A, Paoletti AM, Russo N, Vicariotto F, Villa P, Volpe A, Italian Menopause Society (SIM). Menopause and hormone replacement therapy: the 2017 recommendations of the Italian Menopause Society. Minerva Ginecol. 2018;70(1):27–34.

    PubMed  Google Scholar 

  6. Bachmann GA, Komi JO. Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study. Menopause. 2010;17(3):480–6.

    PubMed  Google Scholar 

  7. Portman DJ, Bachmann GA, Simon JA. Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy. Menopause. 2013;20(6):623–30.

    Article  Google Scholar 

  8. Portman D, Palacios S, Nappi RE, Mueck AO. Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial. Maturitas. 2014;78(2):91–8.

    Article  CAS  Google Scholar 

  9. Tadir Y, Gaspar A, Lev-Sagie A, et al. Light and energy based therapeutics for genitourinary syndrome of menopause: consensus and controversies. Lasers Surg Med. 2017;49(2):137–59.

    Article  Google Scholar 

  10. Gambacciani M, Palacios S. Laser therapy for the restoration of vaginal function. Maturitas. 2017;99:10–5.

    Article  Google Scholar 

  11. Gaspar A, Addamo G, Brandi H. Vaginal fractional CO2 laser: a minimally invasive option for vaginal rejuvenation. Am J Cosmet Surg. 2011;28:156–62.

    Article  Google Scholar 

  12. Salvatore S, Nappi RE, Zerbinati N, et al. A 12-weeks treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric. 2014;17(4):363–9.

    Article  CAS  Google Scholar 

  13. Salvatore S, Nappi RE, Parma M, et al. Sexual function after fractional microablative CO2laser in women with vulvovaginal atrophy. Climacteric. 2015;18:219–25.

    Article  CAS  Google Scholar 

  14. Vizintin Z, Lukac M, Kazic M, Tettamanti M. Erbium laser in gynecology. Climacteric. 2015;18(suppl 1):4–8.

    Article  Google Scholar 

  15. Gaspar A. Comparison of new minimally invasive Er:YAG laser treatment and hormonal replacement therapy in the treatment of vaginal atrophy. Climacteric. 2014;17(Suppl 1):48–108.

    Google Scholar 

  16. Lapii GA, Yakovleva AY, Neimark AI. Structural reorganization of the vaginal mucosa in stress urinary incontinence under conditions of Er:YAG laser treatment. Bull Exp Biol Med. 2017;162:510–4.

    Article  CAS  Google Scholar 

  17. Gambacciani M, Levancini M. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause. Minerva Ginecol. 2015;67(2):97–102.

    CAS  PubMed  Google Scholar 

  18. Gambacciani M, Levancini M. Vaginal erbium laser: the second generation thermotherapy for the genitourinary syndrome of menopause (GSM) in breast cancer survivors. A preliminary report of a pilot study. It J Gynaecol Obstet. 2015;27:15–7.

    Google Scholar 

  19. Gambacciani M, Levancini M, Cervigni M. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Climacteric. 2015;18:757–63.

    Article  CAS  Google Scholar 

  20. Fistonić N, Fistonić I, Lukanovič A, FindriGuštek Š, SortaBilajacTurina I, Franić D. First assessment of short-term efficacy of Er:YAG laser treatment on stress urinary incontinence in women: prospective cohort study. Climacteric. 2015;18:37–42.

    Article  Google Scholar 

  21. Lee MS. Treatment of vaginal relaxation syndrome with an erbium: YAG laser using 90° and 360° scanning scopes: a pilot study & short-term results. Laser Ther. 2014;23:129–38.

    Article  Google Scholar 

  22. Ogrinc UB, Senčar S, Lenasi H. Novel minimally invasive laser treatment of urinary incontinence in women. Lasers Surg Med. 2015;47(9):689–97.

    Article  Google Scholar 

  23. Pardo JI, Solà VR, Morales AA. Treatment of female stress urinary incontinence with erbium-YAG laser in non-ablative mode. Eur J Obstet Gynecol Reprod Biol. 2016;204:1–4.

    Article  Google Scholar 

  24. Fistonic N, Fistonic I, Findri-Gustek S, Bilajac Turina I, Kristofic I, Franic D. Minimally invasive, non-ablative Er:YAG laser treatment of stress urinary incontinence in women—a pilot study. Lasers Med Sci. 2016;31:635–43.

    Article  Google Scholar 

  25. Gambacciani M, Torelli MG, Martella L, et al. Rationale and design for the vaginal erbium laser academy study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence. Climacteric. 2015;18(Suppl 1):43–8.

    Article  Google Scholar 

  26. Gambacciani M, Levancini M. Vaginal erbium laser as second generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors. Menopause. 2017;24(3):316–9.

    Article  Google Scholar 

  27. Gaspar A, Brandi H, Gomez V, Luque D. Efficacy of erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Laser Surg Med. 2017;49:160–8.

    Article  Google Scholar 

  28. Gambacciani M, Levancini M, Russo E, Vacca L, Simoncini T, Cervigni M. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause. Climacteric. 2018;21(2):148–52.

    Article  CAS  Google Scholar 

  29. Blaganje M, Šcepanovic D, Žgur L, Verdenik I, Pajk F, Lukanovic A. Non-ablative Er:YAG laser therapy effect on stress urinary incontinence related to quality of life and sexual function: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2018;224:153–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Pisa University Hospital, Pisa, Italy

    Marco Gambacciani

Authors
  1. Marco Gambacciani
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, University of Zaragoza Facultad de Medicina, Zaragoza, Spain

    Faustino R. Pérez-López

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gambacciani, M. (2019). Laser Treatment for Vulvovaginal Atrophy. In: Pérez-López, F. (eds) Postmenopausal Diseases and Disorders. Springer, Cham. https://doi.org/10.1007/978-3-030-13936-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-13936-0_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-13935-3

  • Online ISBN: 978-3-030-13936-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation